nach oben

World Journal of Urology

Erschienen in:

01.04.2010 | Topic Paper

Thulium:YAG 2 μm cw laser prostatectomy: where do we stand?

verfasst von: T. Bach, S. J. Xia, Y. Yang, S. Mattioli, G. M. Watson, A. J. Gross, T. R. W. Herrmann

Erschienen in: World Journal of Urology | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Tm:YAG 2 μm cw laser prostatectomy was introduced in the treatment of benign ptostatic obstruction (BPO). Since then numerous studies have been published proving efficacy during follow-up. However, different surgical techniques were introduced with different names for similar techniques that complicate comparison. This reviews aim was to compare published data and break down surgical techniques to core points. The authors define validate appellations for different surgical techniques and propose further use of these names to ensure homogenous nomenclature.

Materials and methods

All publications on Thulium:YAG prostatectomy have been included in this review. Articles were reviewed and associated due to the nature of the surgical approach. A systematic review of published data was performed.

Results

Sixteen peer-reviewed publications dealing with Tm:YAG laser prostatectomy were printed since 2005. Four different surgical principles are described, including vaporization, resection and enucleation. Follow-up, up to 24 months, showed durable functional results.

Conclusion

Efficacy of Tm:YAG prostatectomy was shown. Surgical techniques include “Tm:YAG Vaporization of the prostate (ThuVAP)”, “Tm:YAG VapoResection of the prostate (ThuVaRP)” and “Tm:YAG VapoEnucleation of the prostate (ThuVEP)”. The almost blunt enucleation is introduced as “Tm:YAG laser enucleation of the prostate (ThuLEP)”. The authors recommend the use of this neologism in the future. Further, large-scale prospective studies are needed to prove long-term durability. To initiate and canalize these upcoming studies, the Urothulium Study Group^© was founded, combining international experts on Thulium:YAG laser prostatectomy under its roof.

Xia SJ, Zhang YN, Lu J, Sun XW, Zhang J, Zhu YV, Li WG (2005) Thulium laser resection of prostate-tangerine technique in the treatment of benign prostatic hyperplasia. Zhonghua Yi Xue Za Zhi 85:3225–3228PubMed

Bach T, Herrmann TRW, Ganzer R, Burchardt M, Gross AJ (2007) RevoLix vaporesection of the prostate: initial results of 54 patients with a one-year follow-up. World J Urol 25:257–262CrossRefPubMed

Xia SJ (2009) Two-micron (thulium) laser resection of the prostate-tangerine technique: a new method for BPH treatment. AJA 11:277–281PubMed

Herrmann TR, Bach T, Imkamp F, Georgiou A, Burchardt M, Oelke M, Gross AJ (2010) Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol 28:45–51

Wendt-Nordahl G, Huckele S, Honeck P, Alken P, Knoll T, Michel MS, Haecker A (2008) Systemic evaluation of recently introduced 2-μm continuous-wave thulium laser for vaporesection of the prostate. J Endourol 22:1041–1045CrossRefPubMed

Bach T, Huck N, Wezel F, Haecker A, Gross AJ, Michel MS (2009) 70 vs. 120 W thulium:yttrium-aluminium-garnet 2 μm continuous-wave laser for the treatment of benign prostatic hyperplasia: a systemic ex-vivo evaluation. BJU Int (Nov 13 [Epub ahead of print])

Fu WJ, Hong BF, Yang Y, Zhang X, Gao JP, Zhang L, Wang XX (2008) Vaporesection for managing benign prostatic hyperplasia using a 2-μm continuous—wave laser: a prospective trial with 1-year follow-up. BJU Int 103:352–356CrossRefPubMed

Xia SJ, Zhuo J, Sun XW, Han BM, Shao Y, Zhang YN (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53:382–389CrossRefPubMed

Mattioli S, Munoz R, Recasens R, Berbegal C, Cortada J, Urmeneta JM, Teichmann H (2008) Treatment of benign prostatic hypertrophy with the Revolix laser. Arch Esp Urol 61:1037–1043PubMed

10.

Szlauer R, Götschl R, Razmaria A, Paras L, Schmeller NT (2009) Endoscopic vaporesection of the prostate using the continuous-wave 2-μm thulium laser: outcome and demonstration of the surgical technique. Eur Urol 55:368–375CrossRefPubMed

11.

Shao Q, Zhang FB, Shang DH, Tian Y (2009) Comparison of holmium and thulium laser in transurethral enucleation of the prostate. Zhonghua Nan Ke Xue 15:346–349PubMed

12.

Bach T, Herrmann TRW, Ganzer R, Blana A, Burchardt M, Gross AJ (2009) Thulum:YAG vaporesection of the prostate. First results. Urologe 48:529–534CrossRefPubMed

13.

Bach T, Wendt-Nordahl G, Michel MS, Herrmann TRW, Gross AJ (2009) Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate. World J Urol 27:541–545CrossRefPubMed

14.

Bach T, Herrmann TRW, Haecker A, Michel MS, Gross AJ (2009) Thulium:yttrium-aluminium-garnet laser prostatectomy in men with refractory urinary retention. BJU Int 104:361–364CrossRefPubMed

15.

Fu WJ, Zhang X, Yang Y, Hong BF, Gao JP, Cai W, Zhang P, Wang XX (2009) Comparison of 2-μm continuous wave laser vaporesection of the prostate and transurethral resection of the prostate: a prospective nonrandomized trial with 1-year follow-up. Urology 75:194–199

16.

Bach T, Netsch C, Haecker A, Michel MS, Herrmann TRW, Gross AJ (2010) Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol 28:39–43

17.

Heinrich E, Wendt-Nordahl G, Honeck P, Alken P, Knoll T, Michel MS, Haecker A (2010) 120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model. J Endourol 24:75–79CrossRefPubMed

18.

Naspro R, Bachmann A, Gilling P, Kuntz R, Madersbacher S, Montorsi F, Reich O, Stief C, Vavassori I (2009) A review of the recent evidence (2006–2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate. Eur Urol 55(6):1345–1357CrossRefPubMed

Titel: Thulium:YAG 2 μm cw laser prostatectomy: where do we stand?
verfasst von: T. Bach
S. J. Xia
Y. Yang
S. Mattioli
G. M. Watson
A. J. Gross
T. R. W. Herrmann
Publikationsdatum: 01.04.2010
Verlag: Springer-Verlag
Erschienen in: World Journal of Urology / Ausgabe 2/2010
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-010-0522-x

Neu im Fachgebiet Urologie

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Thulium:YAG 2 μm cw laser prostatectomy: where do we stand?

Abstract

Introduction

Materials and methods

Results

Conclusion

Neu im Fachgebiet Urologie

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Fehlerkultur in der Medizin – Offenheit zählt!

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

Update Urologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Introduction

Materials and methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2010

Lymphovascular invasion in radical cystectomy specimen: is it an independent prognostic factor in patients without lymph node metastases?

Vascular risk factors and their association to serum androgen levels in a population-based cohort of 75-year-old men over 5 years: results of the VITA study

Ureteroscopic laser treatment of upper urinary tract neoplasms

X-ray-free percutaneous nephrolithotomy in supine position with ultrasound guidance

Clinical observation on 2 micron laser for non-muscle-invasive bladder tumor treatment: single-center experience

Perioperative analgesia strategies in fast-track pediatric surgery of the kidney and renal pelvis: lessons learned

Neu im Fachgebiet Urologie

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Fehlerkultur in der Medizin – Offenheit zählt!

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

Update Urologie